PPD Laboratories Opens Central Lab in Shanghai, China
News Apr 24, 2015
Pharmaceutical Product Development, LLC (PPD) has opened a central laboratory in Shanghai, China, to deliver global scientific and technical laboratory expertise to meet growing client demand for these services in China.
The new facility, which has been established in association with Shanghai Clinical Research Center (SCRC), is equipped with cutting-edge analytical equipment to provide high-quality data across a wide range of technologies and applications for all phases of pharmaceutical development.
The central lab service offering of PPD® Laboratories includes safety and general lab testing, specialized testing, biomarker testing, and custom assay development and testing services. This new operation provides the same services as PPD’s other central labs in Brussels, Belgium; Highland Heights, Kentucky; and Singapore.
All of PPD’s central labs use identical testing platforms, calibrators and reagents for all laboratory assays. In addition, the same lot numbers of standards for calibration are used across all labs, ensuring identical results regardless of where testing is performed.
“Our global network of central labs is committed to bringing value across the product development continuum,” said Andrew Cunningham, Ph.D., vice president of global laboratory services at PPD. “We deliver world-class scientific expertise, innovative platforms, flexible service models and operational efficiencies to ensure successful execution across every step of the development process. The standardized, global platforms and Web-based database of our central labs ensure superior service, quality data, and exceptional speed and flexibility for our clients.”
The Shanghai laboratory leverages PPD’s 30 years of global laboratory expertise, broad therapeutic experience, and facilities and instrumentation in delivering best-in-class laboratory services for its clients.
The new facility is accredited via SCRC’s medical license issued by China’s Ministry of Health, as well as the College of American Pathologists, NGSP and ISO 15189 certifications-all of which are crucial to conducting clinical trials in China successfully.
In addition to central labs, PPD Laboratories also includes: good manufacturing practices (GMP) labs in Athlone, Ireland, and Middleton, Wisconsin; bioanalytical labs in Middleton and Richmond, Virginia; and vaccine sciences labs in Richmond and Wayne, Pennsylvania. PPD also has strong clinical development expertise, which is supported by 20 facilities throughout the Asia Pacific region.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Medherant Expands Team with Appointment of David Davies as Head of DevelopmentNews
Medherant Ltd, a leader in next-generation transdermal drug delivery, is pleased to announce the appointment of a new senior executive, David Davies, as Head of Development.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018